| Mary Kathleen Hirschi, CNM | |
|
6701 Fannin St, Houston, TX 77030-2608 | |
| (832) 824-1000 | |
| Not Available |
| Full Name | Mary Kathleen Hirschi |
|---|---|
| Gender | Female |
| Speciality | Advanced Practice Midwife |
| Location | 6701 Fannin St, Houston, Texas |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1144215294 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 367A00000X | Advanced Practice Midwife | 682930 (Texas) | Primary |
| Entity Name | Texas Childrens Physician Group |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1861675506 PECOS PAC ID: 4385722081 Enrollment ID: O20080422000209 |
News Archive
The Human Papillomavirus (HPV) is the causative agent responsible for most cases of cervical cancer, but is also associated with several other types of cancer.
Scientists at Jefferson Medical College are using tobacco plants to produce monoclonal antibodies – tiny guided protein missiles – that can target and hunt down cancer cells. The plants promise to provide a cheaper, faster method of producing anticancer antibodies, raising hopes that the technology can one day be used in humans.
EffRx Pharmaceuticals SA today announced that the U.S. Food and Drug Administration (FDA) has approved BINOSTO (alendronate sodium) Effervescent Tablets, previously known as EX101, for the treatment of osteoporosis in postmenopausal women, and as a treatment to increase bone mass in men with osteoporosis. EffRx anticipates that BINOSTO will be commercially available in the United States in the third quarter of 2012.
Derma Sciences, Inc., a medical device and pharmaceutical company focused on advanced wound care, announced the launch of its new XTRASORB™ Foam dressing. The dressing is the company's first novel entry in the $300 million foam wound dressing market. First sales are expected during the second quarter of 2010.
An article in CMAJ (Canadian Medical Association Journal) provides an overview on personal protective equipment (PPE) in health care settings, including evidence on effectiveness of N95 masks, as well as the importance of including health care worker perspectives on usage of this equipment.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Mary Kathleen Hirschi, CNM 2 Greenway Plz Ste 300, Houston, TX 77046-0207 Ph: (832) 828-3660 | Mary Kathleen Hirschi, CNM 6701 Fannin St, Houston, TX 77030-2608 Ph: (832) 824-1000 |
News Archive
The Human Papillomavirus (HPV) is the causative agent responsible for most cases of cervical cancer, but is also associated with several other types of cancer.
Scientists at Jefferson Medical College are using tobacco plants to produce monoclonal antibodies – tiny guided protein missiles – that can target and hunt down cancer cells. The plants promise to provide a cheaper, faster method of producing anticancer antibodies, raising hopes that the technology can one day be used in humans.
EffRx Pharmaceuticals SA today announced that the U.S. Food and Drug Administration (FDA) has approved BINOSTO (alendronate sodium) Effervescent Tablets, previously known as EX101, for the treatment of osteoporosis in postmenopausal women, and as a treatment to increase bone mass in men with osteoporosis. EffRx anticipates that BINOSTO will be commercially available in the United States in the third quarter of 2012.
Derma Sciences, Inc., a medical device and pharmaceutical company focused on advanced wound care, announced the launch of its new XTRASORB™ Foam dressing. The dressing is the company's first novel entry in the $300 million foam wound dressing market. First sales are expected during the second quarter of 2010.
An article in CMAJ (Canadian Medical Association Journal) provides an overview on personal protective equipment (PPE) in health care settings, including evidence on effectiveness of N95 masks, as well as the importance of including health care worker perspectives on usage of this equipment.
› Verified 3 days ago
Margot L Ellard, CNM Advanced Practice Midwife Medicare: Accepting Medicare Assignments Practice Location: 7900 Fannin St, Suite 3000, Houston, TX 77054 Phone: 713-791-9100 Fax: 713-791-1016 | |
Dawn Denise Short, CNM Advanced Practice Midwife Medicare: Medicare Enrolled Practice Location: 6624 Fannin St, Suite 1800, Houston, TX 77030 Phone: 713-797-1144 Fax: 713-790-0739 | |
Ms. Paula Wadewitz, Advanced Practice Midwife Medicare: Medicare Enrolled Practice Location: 6410 Fannin St Ste 350, Houston, TX 77030 Phone: 888-488-3627 | |
Samantha Elizabeth Martin, CNM Advanced Practice Midwife Medicare: Medicare Enrolled Practice Location: 18220 State Highway 249 Ste 370, Houston, TX 77070 Phone: 832-698-5515 Fax: 832-698-5516 | |
Anna Laura Chae Clark, MSN Advanced Practice Midwife Medicare: Medicare Enrolled Practice Location: 7400 Fannin St, Suite 1050, Houston, TX 77054 Phone: 713-206-2903 | |
Nilka M. Dulan, CNM Advanced Practice Midwife Medicare: Medicare Enrolled Practice Location: 1504 Taub Loop, Houston, TX 77030 Phone: 713-873-2000 |